12074781

Source:http://linkedlifedata.com/resource/pubmed/id/12074781

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005682, umls-concept:C0027651, umls-concept:C0030705, umls-concept:C0038952, umls-concept:C0085957, umls-concept:C0087111, umls-concept:C0332161, umls-concept:C0442124
pubmed:issue	6
pubmed:dateCreated	2002-6-20
pubmed:abstractText	To study the clinical and pathological factors that affect recurrence, progression and survival in pT1G3 bladder tumours treated conservatively.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7512719
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic, http://linkedlifedata.com/resource/pubmed/chemical/BCG Vaccine
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0302-2838
pubmed:author	pubmed-author:GuilléFrançoisF, pubmed-author:LerayEmmanuelleE, pubmed-author:LobelBernardB, pubmed-author:PatardJean-JacquesJJ, pubmed-author:Rioux-LeclercqNathalieN, pubmed-author:RodriguezAlejandroA
pubmed:issnType	Print
pubmed:volume	41
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	635-41; discussion 642
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:12074781-Adjuvants, Immunologic, pubmed-meshheading:12074781-Administration, Intravesical, pubmed-meshheading:12074781-Adult, pubmed-meshheading:12074781-Aged, pubmed-meshheading:12074781-Aged, 80 and over, pubmed-meshheading:12074781-BCG Vaccine, pubmed-meshheading:12074781-Carcinoma, Transitional Cell, pubmed-meshheading:12074781-Cohort Studies, pubmed-meshheading:12074781-Combined Modality Therapy, pubmed-meshheading:12074781-Cystectomy, pubmed-meshheading:12074781-Disease-Free Survival, pubmed-meshheading:12074781-Female, pubmed-meshheading:12074781-Follow-Up Studies, pubmed-meshheading:12074781-Humans, pubmed-meshheading:12074781-Longitudinal Studies, pubmed-meshheading:12074781-Male, pubmed-meshheading:12074781-Middle Aged, pubmed-meshheading:12074781-Neoplasm Staging, pubmed-meshheading:12074781-Prognosis, pubmed-meshheading:12074781-Proportional Hazards Models, pubmed-meshheading:12074781-Retrospective Studies, pubmed-meshheading:12074781-Urinary Bladder Neoplasms
pubmed:year	2002
pubmed:articleTitle	Intravesical Bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours.
pubmed:affiliation	Department of Urology, CHU, Rennes, France. jean-jacques.patard@chu-rennes.fr
pubmed:publicationType	Journal Article